Get the Stockscreener App
193.76
0.10%
0.19
After Hours:
193.76
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $193.76, with a volume of 1.25M.
It is up +0.10% in the last 24 hours and up +8.22% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$193.57
Open:
$193.82
24h Volume:
1.25M
Relative Volume:
0.64
Market Cap:
$55.30B
Revenue:
$21.84B
Net Income/Loss:
$1.68B
P/E Ratio:
33.24
EPS:
5.8293
Net Cash Flow:
$2.67B
1W Performance:
-0.07%
1M Performance:
+8.22%
6M Performance:
+13.35%
1Y Performance:
-12.50%
1-Day Range:
$192.09
$194.10
1-Week Range:
$189.44
$194.77
52-Week Range:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
193.76 | 55.25B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
568.65 | 201.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
78.99 | 39.31B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.51 | 36.70B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
281.77 | 20.45B | 2.96B | 487.70M | 344.00M | 6.6758 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Ex-Dividend Reminder: Becton, Dickinson, Nicolet Bankshares and UnitedHealth Group - Nasdaq
BD and ChemoGLO collaborate to expand hazardous drug contamination testing for healthcare facilities and laboratories - MarketScreener
BD and ChemoGLO Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories - Finviz
Becton, Dickinson & Co. Working With ChemoGLO Partner to Broaden Hazardous Drug Contamination Testing - MarketScreener
BD and ChemoGLO partner to enhance hazardous drug testing in healthcare By Investing.com - Investing.com South Africa
BD (NYSE: BDX), ChemoGLO partner to speed hazardous drug surface testing to 10 minutes - Stock Titan
Feld Michael, EVP at Becton Dickinson, sells $14502 in stock By Investing.com - Investing.com South Africa
Hundreds of jobs saved at Swindon factory after buyout of US firm - This is Wiltshire
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes - Finviz
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld Michael, EVP at Becton Dickinson, sells $14502 in stock - Investing.com
BDX: Morgan Stanley Raises Price Target on Becton Dickinson | BD - GuruFocus
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $210 - 富途牛牛
Is Becton Dickinson and Company stock good for wealth creationMarket Rally & Verified Chart Pattern Signals - Newser
Europe Glass Prefilled Syringes and Glass Vials Packaging Equipment Market Trends 2035 - GlobeNewswire Inc.
Is Becton, Dickinson and Company Stock Underperforming the Nasdaq? - Barchart.com
Does Europe’s First CE-Approved Surgical Irrigation System Shift the Bull Case for BD (BDX)? - simplywall.st
Becton Dickinson (BDX): Evaluating Valuation After European Launch of Surgiphor and Recent Strategic Moves - simplywall.st
Becton Dickinson Faces Risks in Biosciences and Diagnostic Merger with Waters - MSN
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt? - 富途牛牛
Becton Dickinson (BDX) Margin Decline Reinforces Bearish Revenue Growth Narrative in FY2025 - simplywall.st
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
BECTON DICKINSON & CO SEC 10-K Report - TradingView
Becton Dickinson (NYSE:BDX) Has Announced That It Will Be Increasing Its Dividend To $1.05 - Yahoo Finance
Waters Proposed Acquisition of Becton, Dickinson's Biosciences, Diagnostic Operations Gets EC's Approval - 富途牛牛
How Does Becton Dickinson Stack Up After Regulatory News and Recent Price Swings? - Yahoo Finance UK
Becton Dickinson & Co. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Will Becton Dickinson and Company stock sustain bullish trend into 20252025 Price Action Summary & Fast Entry Momentum Alerts - newser.com
Will Becton Dickinson and Company stock see PE expansion2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
How Do Investors Really Feel About Becton Dickinson & Co? - Benzinga
What Makes Becton Dickinson (BDX) a Good Long-Term Investment? - Insider Monkey
How forex fluctuations impact Becton Dickinson and Company (BOX) stock - newser.com
Barclays Lowers Becton, Dickinson & Co. (BDX) Price Target, Maintains Overweight Rating - MSN
How Becton Dickinson and Company (BOX) stock moves on employment dataWeekly Profit Summary & AI Optimized Trade Strategies - newser.com
Is Becton Dickinson and Company a good long term investmentDouble Top/Bottom Patterns & Rapid Profit Growth - earlytimes.in
Is Becton Dickinson and Company stock ready for a breakoutPortfolio Growth Summary & Capital Efficiency Focused Ideas - newser.com
Becton Dickinson adds two independent directors to board, expands membership - Investing.com Canada
Becton, Dickinson: Our New, Long, Special Situation Investment (BDX) - Seeking Alpha
Becton, Dickinson and Company (BDX) Expands Board with Two New A - GuruFocus
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors - The Malaysian Reserve
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
BD appoints two new directors with healthcare and tech expertise - Investing.com India
Becton Dickinson & Co Expands Board with New Appointments - TradingView
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors :: Becton, Dickinson and Company (BDX) - Becton Dickinson
Becton Dickinson expands HPV screening access with WHO prequalification - Traders Union
Here’s Hinde Group’s Investment Thesis for Becton, Dickinson and Company (BDX) - Insider Monkey
Aristotle Atlantic’s Core Equity Strategy Sold Becton, Dickinson and Company (BDX) Due to Recent Earnings Weakness - Insider Monkey
Becton Dickinson (BDX) Secures Approval for HPV Assay by WHO - GuruFocus
BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification - Financial Times
Is Becton Dickinson and Company stock bottoming out2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Some Investors May Be Willing To Look Past Becton Dickinson's (NYSE:BDX) Soft Earnings - simplywall.st
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):